These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 30288935)

  • 1. Defining specific residue-to-residue interactions between the gp120 bridging sheet and the N-terminal segment of CCR5: applications of transferred NOE NMR.
    Srivastava G; Moseri A; Kessler N; Arshava B; Naider F; Anglister J
    FEBS J; 2018 Nov; 285(22):4296-4310. PubMed ID: 30288935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of intermolecular transferred NOEs in large protein complexes using asymmetric deuteration: HIV-1 gp120 in complex with a CCR5 peptide.
    Srivastava G; Moseri A; Kessler N; Akabayov SR; Arshava B; Naider F; Anglister J
    FEBS J; 2016 Nov; 283(22):4084-4096. PubMed ID: 27701820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of intermolecular transferred-NOE interactions in small and medium size protein complexes: RANTES complexed with a CCR5 N-terminal peptide.
    Abayev M; Srivastava G; Arshava B; Naider F; Anglister J
    FEBS J; 2017 Feb; 284(4):586-601. PubMed ID: 28052516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple binding modes of an N-terminal CCR5-peptide in complex with HIV-1 gp120.
    Moseri A; Akabayov SR; Cohen LS; Naider F; Anglister J
    FEBS J; 2022 Jun; 289(11):3132-3147. PubMed ID: 34921512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The conformation and orientation of a 27-residue CCR5 peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide.
    Schnur E; Noah E; Ayzenshtat I; Sargsyan H; Inui T; Ding FX; Arshava B; Sagi Y; Kessler N; Levy R; Scherf T; Naider F; Anglister J
    J Mol Biol; 2011 Jul; 410(5):778-97. PubMed ID: 21763489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.
    Dogo-Isonagie C; Lam S; Gustchina E; Acharya P; Yang Y; Shahzad-ul-Hussan S; Clore GM; Kwong PD; Bewley CA
    J Biol Chem; 2012 Apr; 287(18):15076-86. PubMed ID: 22403408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies.
    Liu S; Fan S; Sun Z
    J Mol Model; 2003 Oct; 9(5):329-36. PubMed ID: 14517611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An extended CCR5 ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions.
    Abayev M; Moseri A; Tchaicheeyan O; Kessler N; Arshava B; Naider F; Scherf T; Anglister J
    FEBS J; 2015 May; 282(10):1906-1921. PubMed ID: 25703038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4.
    Huang CC; Lam SN; Acharya P; Tang M; Xiang SH; Hussan SS; Stanfield RL; Robinson J; Sodroski J; Wilson IA; Wyatt R; Bewley CA; Kwong PD
    Science; 2007 Sep; 317(5846):1930-4. PubMed ID: 17901336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly conserved beta16/beta17 beta-hairpin structure in human immunodeficiency virus type 1 YU2 gp120 is critical for CCR5 binding.
    Mechulam A; Cerutti M; Pugnière M; Missé D; Gajardo J; Roquet F; Robinson J; Veas F
    J Mol Med (Berl); 2005 Jul; 83(7):542-52. PubMed ID: 15905975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine-sulfate isosteres of CCR5 N-terminus as tools for studying HIV-1 entry.
    Lam SN; Acharya P; Wyatt R; Kwong PD; Bewley CA
    Bioorg Med Chem; 2008 Dec; 16(23):10113-20. PubMed ID: 18952441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120.
    Rizzuto C; Sodroski J
    AIDS Res Hum Retroviruses; 2000 May; 16(8):741-9. PubMed ID: 10826481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120.
    Königs C; Rowley MJ; Thompson P; Myers MA; Scealy M; Davies JM; Wu L; Dietrich U; Mackay CR; Mackay IR
    Eur J Immunol; 2000 Apr; 30(4):1162-71. PubMed ID: 10760806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic analysis of neurotropic HIV envelope sequences identifies polymorphisms in the gp120 bridging sheet that increase macrophage-tropism through enhanced interactions with CCR5.
    Mefford ME; Kunstman K; Wolinsky SM; Gabuzda D
    Virology; 2015 Jul; 481():210-22. PubMed ID: 25797607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes.
    Cormier EG; Tran DN; Yukhayeva L; Olson WC; Dragic T
    J Virol; 2001 Jun; 75(12):5541-9. PubMed ID: 11356961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of intermolecular NOE interactions in large protein complexes.
    Anglister J; Srivastava G; Naider F
    Prog Nucl Magn Reson Spectrosc; 2016 Nov; 97():40-56. PubMed ID: 27888839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A; Feigelson DJ; Hayek Y; Anglister J
    Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling on human CCR5 receptors and complex with CD4 antigens and HIV-1 envelope glycoprotein gp120.
    Yang J; Liu CQ
    Acta Pharmacol Sin; 2000 Jan; 21(1):29-34. PubMed ID: 11263244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications.
    Wang WK; Dudek T; Essex M; Lee TH
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4558-62. PubMed ID: 10200301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants of human immunodeficiency virus type 1 that efficiently use CCR5 lacking the tyrosine-sulfated amino terminus have adaptive mutations in gp120, including loss of a functional N-glycan.
    Platt EJ; Shea DM; Rose PP; Kabat D
    J Virol; 2005 Apr; 79(7):4357-68. PubMed ID: 15767436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.